After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax
The European Medicines Agency has recommended approval of a mCombriax, an mRNA vaccine that protects against COVID-19 and influenza, for people aged 50 years or older, which would allow the continent access to the first combination vaccine for both …